Critical Analysis of Monoclonal Antibody Therapy in Transplantation

Published:
Author(s):

Purchasing Options

Hardback
$279.95
Add to cart
ISBN 9780849368219
Cat# 6821
 

Features

  • Provides an up-to-date critique of OKT3, the first monoclonal antibody to be used successfully in transplant patients
  • Offers a comparative analysis of monoclonal antibody therapy using animal models and human clinical experiences
  • Presents a review of the most extensive clinical experience with anti-IL-2 receptor monoclonal antibody therapy in renal transplant patients and the recent anti-LFA1 trial
  • Examines new models for peripheral tolerance induction by anti-CD4 and anti-CD8 monoclonal antibodies in rodent transplant systems
  • Summary

    Critical Analysis of Monoclonal Antibody Therapy in Transplantation provides a critical analysis of monoclonal antibody therapies in transplantation. The book presents diverse approaches to monoclonal antibody therapy in transplantation and addresses some of the serious obstacles that remain both in understanding these mechanisms and in successfully applying them in clinical situations.

    The background and rationale for OKT3 therapy are examined and an extensive clinical experience with OKT3 induction therapy in cardiac transplantation is reviewed. The book also examines the background and rationale for the use of anti-TcR (??), anti-IL-2R, and anti-LFA-1 monoclonal antibodies in clinical transplantations. Other topics include the use of monclonal antibodies to CD4 and CD8 for the induction of adult transplantation tolerance in rodents and the possibilities for applying anti-idiotypical strategies that have proven useful in autoimmunity models to transplant recipients.

    Researchers and basic scientists involved in this field will find the book a fascinating and useful resource for their investigations.

    Table of Contents

    Anti-CD3-Mediated Immunotherapy: A Murine Model. OKT3 in Allogenic Transplantation: Clinical Efficacy, Mode of Action, and Side Effects. The Use of OKT3 for Induction Therapy in Cardiac Transplantation. Anti-IL-2 Receptor and Anti-LFA-1 Monoclonal Antibodies in Transplantation: Rationale and Nantes Clinical Experience. Transplantation Tolerance with Monoclonal Antibodies. Anti-CD4-Mediated Transplantation Tolerance: Mechanisms and Memory. Prospects for Anti-Idiotype Therapy in Transplantation.

    Related Titles